You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hives

Showing 1 - 25 of 379
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urticaria, Chronic Spontaneous Urticaria, Chronic Idiopathic Urticaria Trial (Povorcitinib, Placebo)

Not yet recruiting
  • Urticaria
  • +5 more
  • (no location specified)
Jul 6, 2023

Urticaria Trial (desloratadine)

Completed
  • Urticaria
  • (no location specified)
Feb 7, 2022

Chronic Idiopathic Urticaria, Atopy Trial (desloratadine, Placebo)

Completed
  • Chronic Idiopathic Urticaria
  • Atopy
  • (no location specified)
Feb 7, 2022

Hives Trial in Brooklyn (2% Doxycycline Cream in Generic Aquaphor or Generic Aquaphor)

Active, not recruiting
  • Hives
  • 2% Doxycycline Cream in Generic Aquaphor or Generic Aquaphor
  • Brooklyn, New York
    SUNY Downstate Medical Center
Oct 13, 2021

Pathogenesis of Physical Induced Urticarial Syndromes

Recruiting
  • Hypersensitivity, Immediate
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 18, 2023

    Chronic Spontaneous Urticaria Trial in Germany, Poland, United States (LY3454738, Placebo)

    Terminated
    Has Results
    • Chronic Spontaneous Urticaria
    • Bakersfield, California
    • +24 more
    Feb 14, 2022

    Hernia, Inguinal, Hernia, Femoral Trial (Totally ExtraPeritoneal (TEP) repair, TransAbdominal PrePeritoneal (TAPP) repair, Open

    Completed
    • Hernia, Inguinal
    • Hernia, Femoral
    • Totally ExtraPeritoneal (TEP) repair
    • +5 more
    • (no location specified)
    Jan 13, 2020

    Chronic Inducible Urticaria Trial (Remibrutinib, Placebo)

    Not yet recruiting
    • Chronic Inducible Urticaria
    • (no location specified)
    Jul 28, 2023

    Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • (no location specified)
    Sep 20, 2023

    Chronic Spontaneous Urticaria Trial (LOU064 (blinded), )

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • LOU064 (blinded)
    • placebo
    • (no location specified)
    Dec 23, 2022

    Xolair® in Pediatric Chronic Spontaneous Urticaria in China

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • Xolair
    • (no location specified)
    Sep 19, 2023

    Urticaria, Angiœdema Trial in Colombes (Placebo Oral Tablet, Cortancyl Oral Tablet, Levocetirizine Oral Tablet)

    Recruiting
    • Urticaria
    • Angiœdema
    • Placebo Oral Tablet
    • +2 more
    • Colombes, Ile De France, France
      Hospital Louis MOURIER
    Dec 7, 2022

    Cold Urticaria Trial in Worldwide (Dupilumab SAR231893, Placebo, Non sedating H1-antihistamine)

    Active, not recruiting
    • Cold Urticaria
    • Dupilumab SAR231893
    • +2 more
    • San Diego, California
    • +34 more
    Nov 15, 2022

    Chronic Spontaneous Urticaria Trial in Canada, United States (Oral EP262, Placebo)

    Recruiting
    • Chronic Spontaneous Urticaria
    • Oral EP262
    • Placebo
    • Birmingham, Alabama
    • +7 more
    Oct 5, 2023

    Chronic Inducible Urticaria Trial in Worldwide (Ligelizumab, Placebo)

    Terminated
    • Chronic Inducible Urticaria
    • Litchfield Park, Arizona
    • +64 more
    Jan 26, 2023

    Food Hypersensitivity Trial (Fish oil, Cod oil, Krill oil)

    Not yet recruiting
    • Food Hypersensitivity
    • Fish oil
    • +2 more
    • (no location specified)
    Jan 5, 2023

    Chronic Spontaneous Urticaria Trial in Hungary, United States (barzolvolimab, Matching Placebo)

    Recruiting
    • Chronic Spontaneous Urticaria
    • barzolvolimab
    • Matching Placebo
    • Birmingham, Alabama
    • +44 more
    Dec 8, 2022

    Class II Furcation Defects Management Using Propolis Trial in Cairo (class II furcation defects management using propolis)

    Not yet recruiting
    • Class II Furcation Defects Management Using Propolis
    • class II furcation defects management using propolis
    • Cairo, El-Manial, Egypt
      Cairo university
    Sep 23, 2023

    Urticaria Chronic Trial in Baltimore (Omalizumab)

    Completed
    Has Results
    • Urticaria Chronic
    • Baltimore, Maryland
      Johns Hopkins Asthma and Allergy Center
    May 20, 2021

    Chronic Spontaneous Urticaria Trial in Japan (LOU064)

    Recruiting
    • Chronic Spontaneous Urticaria
    • Nagoya, Aichi, Japan
    • +11 more
    Jul 14, 2022

    Cause of Unexplained Anaphylaxis

    Recruiting
    • Idiopathic Anaphylaxis
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 12, 2023

      Urticaria Trial (Desloratadine, Cetirizine, )

      Terminated
      • Urticaria
      • (no location specified)
      Feb 7, 2022

      STOP CSUA: phySical acTivity, mOod and sleeP in Chronic

      Not yet recruiting
      • Chronic Spontaneous Urticaria
      • Physical activity monitoring - Symptom monitoring
      • Dublin, Ireland
        St. James's Hospital
      Dec 13, 2021

      Chronic Spontaneous Urticaria Trial in Worldwide (Tezepelumab Dose 1, Tezepelumab Dose 2, Omalizumab)

      Recruiting
      • Chronic Spontaneous Urticaria
      • Tezepelumab Dose 1
      • +3 more
      • Birmingham, Alabama
      • +81 more
      Aug 4, 2022

      Urticaria Trial (Desloratadine)

      Completed
      • Urticaria
      • (no location specified)
      Feb 7, 2022